Advances in Breast Cancer: Updates from San Antonio and ESMO

February 22, 2020

Agenda

Each session will share one practice-changing abstract presented at either the 2019 San Antonio Breast Symposium or ESMO, summarize the presented information's impact on clinical practice, and explore a breast cancer case vignette illustrating the implications of the new data on patient care and treatment. Following each expert faculty's presentation will be 10 minutes set aside for Q&A.

Saturday, February 22, 2020

7:00am

Registration Opens & Breakfast Available in Exhibit Hall

7:50am

Welcome & Introductions

8:00am

(01) Latest on Genetic Testing in Breast Cancer  
» Anosheh Afghahi, MD, MPH - University of Colorado

8:30am

(02) Radiation in Breast Cancer
» Christine Fisher, MD, MPH - University of Colorado 

9:00am (03) Neoadjuvant Chemotherapy
» Sami Diab, MD - Rocky Mountain Cancer Center
9:30am
  (04) Triple Negative Breast Cancer
» Jennifer Diamond, MD - University of Colorado

10:00am

Break -  Refreshments in Exhibit Hall

10:20am

(05) Update on Hormonal Therapy
» Peter Kabos, MD - University of Colorado

10:50am (06) Biology of Breast Cancer
» Jennifer Richer, PhD - University of Colorado
11:20am (07) Update on Immunotherapy and IO Toxicity Management
» Jennifer Diamond, MD - University of Colorado 

12:05pm

Buffet Lunch & Non-CE Symposium
Speaker: Anne O'Dea, MD
Topic:  Innovative Oral Treatment Options for Patients: HR+/HER2-MBC or gBRCA-Mutated TNBC and HR+/HER2-MBC
Sponsor: Pfizer Oncology

12:55pm

Dessert Break in Exhibit Hall

1:15pm

(08) HER2+ Breast Cancer: Advances in Early Stage Disease
» Virginia Borges, MD - University of Colorado

1:45pm

(09) HER2+ Breast Cancer: Advances in Metastatic Disease
» Keren Sturtz, MD - SCL Health

2:15pm (10) Stump the Faculty
2:45pm Adjourn
   
Register
Course starts in 3 days

$30 - $125 (registration varies based on designation)